Newly published research proves that it's possible to treat high blood pressure by using specially engineered Lactobacillus paracasei to produce a protein called ACE2 in the gut, reducing gut angiotensin II and, in turn, lowering blood pressure. The study, done in lab rats that are predisposed to hypertension and unable to naturally produce ACE2, opens new doors in the pursuit of harnessing our body's own microbiome to regulate blood pressure.
Read more …Study shows engineered gut bacteria can treat hypertension
Recent research has found that backers of crowdfunding projects participate, in part, because they enjoy a sense of indirect success and the feeling that they are contributing to something bigger than themselves.
Read more …Givers to crowdfunding campaigns enjoy vicarious success
New research shows that automated insulin delivery technology could be a game changer for pregnant women with type 1 diabetes. The technology -- known as 'hybrid closed-loop technology' -- gives insulin doses as informed by a smartphone algorithm. The new study shows that it could help pregnant women better manager their blood sugars compared to traditional insulin pumps or multiple daily injections. Lead researcher Prof Helen Murphy from UEA said: 'This technology is game changing, in that it will allow more women to have safer, healthier, more enjoyable pregnancies, with potential for lifelong benefits for their babies.'
Read more …New technology 'game changing' for pregnant women with diabetes